Close

BTIG Starts Clementia Pharmaceuticals Inc. (CMTA) at Buy

August 31, 2017 7:06 AM EDT Send to a Friend
BTIG initiates coverage on Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) with a Buy rating and a price target of $32.00.Analyst Robert ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login